Company Overview

Medalogix develops machine learning-powered predictive analytics specifically for home health and hospice agencies. Its models predict which patients are at risk for hospitalization, which home health patients may be appropriate for hospice care, and when care interventions are most likely to be effective — enabling proactive rather than reactive care management.

Medalogix's products use clinical and claims data already present in home health EHRs to generate actionable predictions at the patient level — without requiring new data collection. The Bridge product predicts hospice eligibility among home health patients, while Muse predicts hospitalization risk. For value-based care programs, hospitalization prediction is directly tied to financial outcomes.

Predictive AnalyticsHome HealthHospitalization RiskHospiceValue-Based CareMachine LearningNashville

Products & Platform

Muse
Hospitalization risk prediction for home health patients — identifying who is most likely to be hospitalized so care teams can prioritize preventive interventions.
Bridge
Hospice eligibility prediction for home health patients — identifying patients who may benefit from hospice care, enabling timely conversations and appropriate transitions.
Analytics Dashboard
Population-level risk stratification and outcome tracking for home health clinical and operational leadership.

Market Position

Medalogix occupies the predictive analytics niche within home health — layering AI-generated risk scores on top of existing EHR data rather than replacing EHR platforms. This add-on positioning makes Medalogix compatible with any major home health EHR and reduces adoption friction significantly.

Key Data & Metrics

MetricDetail
Founded2011
HeadquartersNashville, TN
ProductsMuse (hospitalization risk), Bridge (hospice eligibility)
Market FocusHome health predictive analytics

Recent News & Developments

2024–2025
HHVBP model drives home health adoption of hospitalization prediction tools
Value-based purchasing payment adjustments tied to hospitalization rates create direct financial incentive for agencies to adopt predictive risk tools like Muse.
2024
Hospice eligibility prediction gains traction as late transition problem recognized
Growing awareness of the cost and quality impact of late hospice transitions drives adoption of Bridge among home health agencies.

How Dorthea Uses This Technology Category

Dorthea's AI co-pilot helps families understand how platforms like Medalogix affect the quality and accountability of senior care facilities and home care agencies they are evaluating. Our free guidance helps families ask the right questions.